First known U.S. Omicron case found in fully vaccinated overseas traveler
- Dow closes lower after disappointing bank results
- JPMorgan (JPM) Stock Falls 5% After Q4 Results, Top-Line Beats but 2022 Expense Outlook Disappoint, Analyst Expects Rising Wage Inflation to be a Key Earnings Theme
- Netflix raises monthly subscription prices in U.S., Canada
- Apple (AAPL) Stock Receives Three Price Targets Hikes Today, Wedbush Positive on Live Sports Content Opportunity
- Wells Fargo (WFC) Tops Street Estimates, Profit Fueled by Loan Demand and Cost Cuts
FILE PHOTO: A vial and a syringe are seen in front of a displayed United States' flag and words "Omicron SARS-CoV-2" in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/Illustration
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
By Trevor Hunnicutt
WASHINGTON (Reuters) - The United States on Wednesday identified its first known case of Omicron, discovered in a fully vaccinated patient who traveled to South Africa, as scientists continue to study the risks the new COVID variant could pose.
Public health officials said the infected person, who had mild symptoms, returned to the United States from South Africa on Nov. 22 and tested positive seven days later.
That patient was fully vaccinated but did not have a booster shot, according to Dr. Anthony Fauci, the top U.S. infectious disease official, who briefed reporters at the White House.
The person is in self-quarantine and all of the patient's close contacts have tested negative so far, he said.
Key questions remain about the new variant, which has rattled markets amid signs it may spread quickly and evade some of the defenses provided by vaccines. It has been found in two dozen countries, including Spain, Canada, Britain, Austria and Portugal.
Fauci said it could take two weeks or more to gain insight into how easily the variant spreads from person to person, how severe is the disease it causes and whether it can bypass the protections provided by vaccines currently available.
"We don't have enough information right now," said Fauci, who serves as an adviser to President Joe Biden, adding that the variant's molecular profile "suggests that it might be more transmissible, and that it might elude some of the protection of vaccines, but we don't know that now... We have to be prepared that there's going to be a diminution in protection."
For days, U.S. health officials have said the new variant -first detected in southern Africa and announced on Nov. 25 - was likely already in the United States as dozens of other countries also detected its presence.
"This new variant is a cause for concern but not a cause for panic," Biden said on Wednesday before the Omicron case was announced. A spokesperson, Jen Psaki, said he the president had been briefed by his team on the first known case.
The United States has barred nearly all foreigners who have been in one of eight southern African countries. On Tuesday, the U.S. Centers for Disease Control and Prevention (CDC) directed airlines to disclose names and other information of passengers who have been to those countries.
(Reporting by Trevor Hunnicutt, Ahmed Aboulenein and Nandita Bose in Washington, and Mrinalika Roy in Bengaluru; Editing by Anil D'Silva and Lisa Shumaker)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. Supreme Court blocks Biden vaccine-or-test policy for large businesses
- Macau keeps casino licences limited to six, halves duration
- Volkswagen Group China's component factory in Tianjin resumes some shifts
Create E-mail Alert Related CategoriesFDA, General News, Reuters, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!